Stock A229000 GENCURIX INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Gencurix Inc.

Equities

A229000

KR7229000005

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 28/05/2024 am IST 		5-day change 1st Jan Change
3,060 KRW -1.77% Intraday chart for Gencurix Inc. -0.49% -50.80%
15/04 J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion. CI
03/04 J&L Agent Co., Ltd. and other buyer agreed to acquire 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3.2 billion. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion.
CI
J&L Agent Co., Ltd. and other buyer agreed to acquire 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3.2 billion.
CI
Gencurix Inc. announced that it has received KRW 3.99999552 billion in funding from HLB PANAGENE Co., LTD.
CI
HLB PANAGENE Co., LTD. announced that it has received KRW 2 billion in funding from Gencurix Inc.
CI
HLB PANAGENE Co., LTD. announced that it expects to receive KRW 2 billion in funding from Gencurix Inc.
CI
Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.
CI
Abion Inc. announced that it expects to receive KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.
CI
Gencurix Inc. Obtains Approval for Companion Diagnostic of Digital Pcr-Based Egfr Mutation Test
CI
Gencurix Announces Clinical Research Results at Asco Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, Oncotypedx
CI
Gencurix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Gencurix Announces Korean and Japanese Cancer Patients' 15-Year Follow-Up Prognostic Test Clinical Results
CI
Gencurix to Raise 28 Billion Won From Stock Offering
MT
Gencurix Inc. announced that it has received KRW 26.9999819 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Aju IB Investment Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm and other investors
CI
Gencurix Inc. announced that it expects to receive KRW 26.9999819 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Aju IB Investment Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm and other investors
CI
Gencurix Inc. announced that it has received KRW 2 billion in funding
CI
Gencurix Inc. announced that it expects to receive KRW 2 billion in funding
CI
Gencurix Inc. agreed to acquire a 41% stake in Nano Bio Life Co., Ltd. from Soo-kyung Kim, Jihye Cheon, Injoong Kim, Ki-moon Song, Jichul Hyun and Sujin Lee for KRW 3.7 billion.
CI
Gencurix Inc. Receives U.S. Food and Drug Administration's Emergency Use Authorization for Its GenePro SARS-CoV-2 Test
CI
Gencurix to Release New Coronavirus Diagnostic Kit in the EU
CI
Gencurix Inc. announced that it has received KRW 1.299999 billion in funding from AJU Capital Co., Ltd., Samsung Securities Co. Ltd., Investment Arm
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A229000 Stock
  4. News Gencurix Inc.